The QualityStocks Daily Friday, November 2nd, 2018

Today's Top 3 StockMarketWatch

NetworkNewsWire (GTXO) +90.00%

BUYINS.NET (PACB) +67.63%

QualityStocks (DXIEF) +33.18%

The QualityStocks Daily Stock List

Bullfrog Gold Corp. (BFGC)

PennyStockLocks.com, StockBomb.com, StockLockandLoad, Wall Street Mover, PennyStocks24, TopPennyStockMovers, InvestorTrendz, Pumps and Dumps, HEROSTOCKS, and Liquid Pennies reported previously on Bullfrog Gold Corp. (BFGC), and we report on the Company as well, here at the QualityStocks Daily Newsletter.

Bullfrog Gold Corp. is a mineral exploration company listed on the OTC Markets’ OTCQB. The Company has a strong asset portfolio with large prospective gold exploration projects located in productive mining districts within the south-western United States. Bullfrog Gold principally explores for gold, silver, and other metals. Bullfrog Gold has its head office in Grand Junction, Colorado.

The Company has its Bullfrog Project. The Bullfrog Project is approximately three miles northwest of the town of Beatty and 116 miles northwest of Las Vegas, Nevada. The Bullfrog Gold Project is in the prolific Walker Trend. Barrick Gold Corp. produced 2.1 million ounces of gold during the 1990’s from the main Bullfrog open pit, the northern one third of which is presently controlled by Bullfrog Gold.

In addition, Bullfrog Gold's lands include the entire Montgomery-Shoshone (M-S) deposit, from which Barrick produced an additional 220,000 ounces of gold. Additionally, the M-S area produced 70,000 ounces averaging 0.47 gold ounce per ton from underground mining operations in the early 1900's.

Bullfrog Gold executed an option in October 2014 to purchase 12 strategic patented claims situated contiguous to its lands and that include the north-east half of the M-S open pit mine. In March of 2015, the Company exercised a lease/option to purchase 6 patented claims, 20 unpatented claims, and 8 mill site claims from Barrick Bullfrog, Inc.

The M-S and Bullfrog deposits are amenable to heap leaching. They can support a mine cut-off grade of 0.2 g/t for leaching at coarse ROM sizes. Bullfrog Gold announced in June 2017 a base case, maiden resource estimate of 525,000 ounces of gold averaging 1.02 g/t on its Bullfrog Gold Project.

Bullfrog Gold announced in July 2017 the leasing of an additional 24 patented mining claims and the staking of 62 new mining claims at its Bullfrog Gold Project. The new lands may permit more expansions to the Montgomery-Shoshone (M-S) and Bullfrog open pit mines, have a number of worthy exploration targets, and provide more sites for heap leach pads and other project facilities.

This past August, Bullfrog Gold announced that Tetra Tech, Inc.'s NI 43-101 resource report on the Bullfrog Gold Project was posted on the website www.bullfroggold.com. The results of the report were released on June 27, 2017.

The results included measured and indicated (M&I) resource estimates of 525,000 ounces averaging 1.02 g/t using a gold price of $1200/oz and a base case cutoff grade of 0.36 g/t. Inferred resources were estimated at 120,000 ounces of gold averaging 1.20 g/t. The estimates are supported by a database, which includes 1,262 holes containing 155 miles of coring and drilling.

Bullfrog Gold Corp. (BFGC), closed Friday's trading session at $0.0621, up 4.99%, on 13,500 volume with 1 trade. The average volume for the last 3 months is 25,933 and the stock's 52-week low/high is $0.052/$0.17.

chart

OncBioMune Pharmaceuticals, Inc. (OBMP)

MissionIR, Otcstockexchange, Whisper from Wall Street, and Journal Transcript reported on OncBioMune Pharmaceuticals, Inc. (OBMP), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.

OncBioMune Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company. It engages in the development of targeted cancer therapies, a proprietary cancer vaccine technology, and commercialization of a portfolio of products globally. OncBioMune has a proprietary Vaccine Technology designed to stimulate the immune system to attack its own cancer while not hurting the patient. The Company incorporates scientifically proven and clinically validated treatments for cancer. OncBioMune Pharmaceuticals is based in Baton Rouge, Louisiana. The Company lists on the OTCQB.

OncBioMune Pharmaceuticals’ lead product is ProscaVax™. This is its novel cancer vaccine for prostate cancer. ProscaVax is now undergoing evaluation in a Phase 1 clinical study at the University of California San Diego Moores Cancer Center and Veterans Hospital in La Jolla, California, funded in part by the Department of Defense US Navy Cancer Vaccine Program.

ProscaVax consists of a combination of prostate cancer associated PSA with the biological adjuvants interleukin-2 (IL-2) and granulocyte-macrophage colony-stimulating factor (GM-CSF). 

Moreover, the Company has a portfolio of targeted therapies. Some of these are biosimilars to blockbuster drugs. OncBioMune has developed the therapeutic cancer vaccine for prostate cancer patients using similar techniques developed for breast cancer patients.

OncBioMune states that it is tested and laboratory proven and that it could become the standard of care for prostate cancer treatment. OncBioMune Pharmaceuticals uses patented technology developed and or acquired by the Company.

In September 2017, OncBioMune Pharmaceuticals announced that it successfully attained development milestones in formulation and stability with tretinoin, also known as all-trans retinoic acid (ATRA). This is an oral drug for the treatment of Acute Promyelocytic Leukemia (APL).  The Company owns the commercialization rights for tretinoin throughout Mexico, Central America, and Latin America.

Earlier this month, OncBioMune Pharmaceuticals provided the latest data from its successfully completed Phase 1 trial of ProscaVax for prostate cancer, suggesting a durable response 31 weeks post-therapy. In the Phase 1 clinical trial, hormone-naïve and hormone-independent recurrent prostate cancer patients with rising prostate specific antigen (PSA) were treated with six intradermal injections of ProscaVax.

Dr. Jonathan Head, Chief Executive Officer at OncBioMune Pharmaceuticals, said, “I’m very excited about this data, as I can’t think of another study to have 75 percent of recurrent prostate cancer patients with rising PSA experience stable disease nearly eight months after therapy ended. .. Now, we have to expand the therapeutic range and increase the number of patients enrolled in mid-stage research, but the data to date certainly is encouraging to provide a safe and effective treatments for the millions of men battling prostate cancer today.”

OncBioMune Pharmaceuticals, Inc. (OBMP), closed Friday's trading session at $0.0182, up 9.97%, on 376,813 volume with 27 trades. The average volume for the last 3 months is 468,201 and the stock's 52-week low/high is $0.0099/$0.0775.

chart

3PEA International, Inc. (TPNL)

The Next Hot Stock, FeedBlitz, HyperSpeedStocks, Volcano Stocks, OtcWizard, and Nebula Stocks reported on 3PEA International, Inc. (TPNL), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

3PEA International, Inc. is a vertically integrated provider of unique prepaid card programs and processing services. These are for corporate, consumer, and government applications. By way of its PaySign® brand, the Company designs and develops payment solutions, prepaid card programs, as well as customized payment services. 3PEA International has its corporate office in Henderson, Nevada.

Via the PaySign platform, 3PEA International provides an assortment of services. This includes transaction processing, cardholder enrolment, value loading, cardholder account management, reporting, and customer service.

3PEA’s customers include healthcare companies, major pharmaceutical companies, and source plasma providers. In addition, its customers include large multinationals, prestigious universities, and social media companies.

In essence, 3PEA International is a payment processor and debit card program manager. The Company manages programs for many of the world’s largest pharmaceutical manufacturers with copay assistance products designed to maximize new patient acquisition, retention, and adherence. Its customizable prepaid solutions provide major cost savings. This is while improving brand recognition and customer loyalty.

3PEA International has launched the PaySign® brand of prepaid cards. This includes solutions for corporate incentives, payroll, public sector, pharmaceutical co-pay assistance, source plasma donations, general spend reloadable, and other market niches.

The Company has an increased presence in the plasma donation payments space through signing The Interstate Companies and B Positive National Blood Services. 3PEA also entered into an agreement with Visa, whereby 3PEA exclusively issues Visa-branded prepaid cards for the PaySign® brand.

3PEA has expanded its PaySign® brand of prepaid cards to the automotive market with PaySign Connect for Automobile Dealerships. The wide-ranging PaySign Connect prepaid solution is a customizable, multi-purpose platform tailored to the unique needs of auto dealerships.

For Q3 2017, 3PEA International revenue grew 42 percent to $4.0 million versus $2.8 million in the same prior year quarter. Revenue for the nine months ended September 30, 2017 grew 44 percent to $10.6 million from $7.3 million for the same period the year prior.

Gross profit for Q3 2017 increased to $1.86 million versus $1.30 million in the same prior year quarter. Gross profit for the nine months ended September 30, 2017 rose to $4.78 million from $3.30 million for the same period the year prior.

Q3 Net income was $500,168, or $.01 per share. This is in comparison to net income of $480,429 or $.01 per share in the same prior year quarter. Net income for the nine months ended September 30, 2017 was $1,254,004 or $0.03 per share. This is in comparison to $898,040 or $0.02 per share in the same prior year period.

Earlier this month, 3PEA International announced the addition of Bio/Pharma copay offset and reimbursement industry veteran, Mr. Al Negron, to its Executive Team as Senior Vice President Business Development in charge of 3PEA International’s Healthcare vertical.

Mr. Negron is a veteran of the Bio/Pharmaceutical services industry. He has a record of greater than 25 years of success and achievement in speeding up revenue growth, increasing profitability, and expanding market footprints for his Bio/Pharmaceutical clients.

3PEA International, Inc. (TPNL), closed Friday's trading session at $4.26, up 6.50%, on 300,189 volume with 915 trades. The average volume for the last 3 months is 163,783 and the stock's 52-week low/high is $0.4979/$5.33.

chart

Broadway Gold Mining Ltd. (BDWYF)

Streetwise Reports, Stockhouse, Barchart, and InvestorsHub reported on Broadway Gold Mining Ltd. (BDWYF), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.

A resource company, Broadway Gold Mining Ltd. centers on development-stage projects with advanced exploration potential. The Company owns a 100 percent interest in the Madison copper-gold project in the Butte-Anaconda mining region of Montana. Broadway Gold Mining’s shares trade on the OTC Markets Group’s OTCQB. The Company has its corporate office in Vancouver, British Columbia.

The Madison copper-gold project is permitted for exploration. It contains a past-producing underground mine that Broadway Gold Mining has refurbished. The Company is expanding known copper and gold zones, which remain open for development in the mine's perimeter.

Broadway’s exploration program has identified new anomalies across its wide-ranging land package. These provide drill targets believed to be associated with large-scale porphyry mineralization.

The Company identified copper-gold porphyry targets at Madison in 2017, supported by a newly assembled geological model. Phase I and II drilling this year returned high-grade gold and copper intersections from shallower skarn zones. Many high-priority targets, including porphyry, will be the emphasis of Phase III drilling.

In October, Broadway Gold Mining announced the discovery of a new latite porphyry zone of mineralization at its Madison project in the legendary Butte-Anaconda mining region of Montana.

Mr. Duane Parnham, Broadway Gold Mining’s President and Chief Executive Officer, said, "Broadway's technical team has successfully delivered on a fourth major milestone worthy of additional testing by discovering a porphyry system underlying the shallower skarn zones, which were mined in the past and expanded in our recent drilling. Although indications suggest a typical copper porphyry alteration system is present, this new mineralization discovered at Madison exhibits similar characteristics to the latite porphyry hosted at Barrick's Golden Sunlight Mine (GSM) located 36 kilometers away in Whitehall, Montana."

Last month, Broadway Gold Mining announced that, as a result of its recent porphyry discovery, it has staked additional ground to cover favorable geological and geophysical targets in the area of its 100 percent-owned Madison copper-gold project.

The new claims are contiguous to the south of the Company’s active exploration area. The new claims extend the current Madison property footprint to 2,514 acres.

Broadway’s Phase III drilling program continues. The Company is fully funded for completion of the program. Deeper geophysical targets from the 2017 survey appear to trend through the original property boundary onto the newly acquired claims.

Broadway Gold Mining Ltd. (BDWYF), closed Friday's trading session at $0.07, up 16.67%, on 500 volume with 1 trade. The average volume for the last 3 months is 9,437 and the stock's 52-week low/high is $0.021/$0.4326.

chart

Galaxy Gaming, Inc. (GLXZ)

Marketbeat.com, Red Chip, SmallCapVoice, TaglichBrothers, The Green Baron, FeedBlitz, and Stock Profile reported earlier on Galaxy Gaming, Inc. (GLXZ), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Galaxy Gaming, Inc. is the world's largest independent developer, manufacturer, and distributor of casino table games and enhanced systems. The Company develops, manufactures, and distributes innovative proprietary table games, state-of-the-art electronic wagering platforms, and enhanced bonusing systems to land-based, riverboat, cruise ships, and online casinos around the world. Galaxy Gaming has its corporate office in Las Vegas, Nevada and the Company lists on the OTC Markets Group’s OTCQB.

Galaxy Gaming has an installed base of its products on thousands of gaming tables located in hundreds of casinos. The Company sells its products chiefly through its internal sales force, to casinos throughout North America, the Caribbean, the British Isles, Europe, and Africa, and also to cruise ships and internet gaming sites worldwide.

Galaxy Gaming is expanding its international footprint via its partnership with WPT Enterprises, Inc. WPT Enterprises is the owner of the World Poker Tour.

In addition, Galaxy Gaming is the exclusive provider of SpectrumVision. This is a proprietary technology employed to detect invisible markings on playing cards.

Furthermore, by way of its iGaming partner, Games Marketing Ltd., Galaxy Gaming licenses its proprietary table games to the online gaming industry. The Company’s games can be played online at FeelTheRush.com.

This past November, Galaxy Gaming announced its results for the quarter ending September 30, 2017. For Q3 2017 in comparison to Q3 2016, Revenue grew 20 percent to $3,830K. Adjusted EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) decreased 16 percent to $1,278K.

The Company had a pre-tax Loss of $6K versus pretax Income of 1,013K. It had a Net Loss of $28K versus Net Income of $662K. Balance Sheet improvements (in comparison to December 31, 2016) include Cash increasing 37 percent to $3,162K.

Total Debt (gross) decreased 12 percent to $9,846K. Stockholders’ equity rose 14 percent to $5,269K.

Mr. Todd Cravens, Galaxy Gaming’s President and Chief Executive Officer, said, “Our year-over-year revenue growth of 20.0 percent reported for the third quarter of 2017 was the highest quarterly revenue growth reported this year. As has been the case for several quarters, we have been adding staff and other resources to support this growth and our future aspirations. One of the benefits of these investments was realized in September when we received a higher level of licensing from the Nevada Gaming Commission. This licensure allows us to broaden our sales activities in Nevada and gives us a roadmap to pursue licenses in other jurisdictions….”

Galaxy Gaming, Inc. (GLXZ), closed Friday's trading session at $1.23, up 1.65%, on 1,200 volume with 4 trades. The average volume for the last 3 months is 15,336 and the stock's 52-week low/high is $0.51/$1.39.

chart

Santa Fe Gold Corporation (SFEG)

OTC Markets, Zacks, 4-Traders, InvestorsHub, MarketWatch, The Street, Investopedia, Stockflare, StreetInsider, and Stockhouse reported on Santa Fe Gold Corporation (SFEG), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Established in 1991, Santa Fe Gold Corporation’s intention is to establish itself as a significant player in the precious metals mining field. Its objective is to produce substantial cash flow from precious metals holdings. This is while creating a portfolio of high quality exploration and bankable development projects that will ensure future revenue growth. OTCQB-listed, Santa Fe Gold is headquartered in Albuquerque, New Mexico.

The Company’s focus is on Gold, Silver, and Copper, Precious, Industrial and Base metals. Santa Fe Gold’s assets include the Knight’s Peak region of Grant County, New Mexico consisting of the Malone Mines, Patanka, Hillcrest Barranca and Principal Mines, altogether incorporating about 20 mine sites and all situated at Knight’s Peak, together with an expanded area surrounding the Malone Mines in the southern area of Burro Mountains, New Mexico.

In addition, Santa Fe Gold owns very significant holdings in the Playas Lake Bed Area of Hidalgo County. This includes the presences of Titanium ore and other rare earth minerals and deposits.

At the end of November 2017, Santa Fe Gold announced that preparations were underway to start mining production as soon as possible upon completion of the acquisitions and final permitting. Santa Fe is in the closing stage of acquisition of 100 percent of Bullard’s Peak Corporation and Black Hawk Consolidated Mines Company.

The acquisitions include the previously optioned AG1 Silver Mine and all lands surrounding the project. This includes a potential Porphyry Silver Discovery, Cobalt, and Lithium, Manganese and Nickel and all rights to same.

In late December, Santa Fe Gold announced it received an additional US$849,958.17 with more funding expected from International Investment Group and its associated investors, bringing their overall stake in Santa Fe Gold to in excess of $6 Million converted to equity at prices close to recent market quotes.

The Company expects to complete 100 percent of the purchase of Silver Mines: Bullard's Peak Corporation and Black Hawk Consolidated Mines in the opening days of 2018. The expectation is that production will commence in the interim afterward. Furthermore, Santa Fe Gold expects to announce at least four new acquisitions in Q1 of 2018.

Santa Fe Gold President and Chief Executive Officer, Mr. Tom Laws, said in December, "We are delighted with the increased investment in Santa Fe Gold which demonstrates confidence in our ongoing near term plans. We expect to close on the AG1 Silver Mines early in the New Year as well as being able to give additional details on why we are really excited about this and other new acquisitions."

Santa Fe Gold Corporation (SFEG), closed Friday's trading session at $0.08, up 1.27%, on 244,708 volume with 15 trades. The average volume for the last 3 months is 93,863 and the stock's 52-week low/high is $0.0401/$0.197.

chart

RegeneRx Biopharmaceuticals, Inc. (RGRX)

PennyStockProphet, Penny Pick Finders, Planet Penny Stocks, Buzz Stocks, Stock Onion, Stock News Now, TopPennyStockMovers, and SmarTrend Newsletters reported earlier on RegeneRx Biopharmaceuticals, Inc. (RGRX), and we report on the Company as well, here at the QualityStocks Daily Newsletter.

OTCQB-listed, RegeneRx Biopharmaceuticals, Inc. is a clinical-stage drug development company. It centers on tissue protection, repair, and regeneration with a wide-ranging portfolio of product candidates for first-in-class therapeutic peptides. The Company’s mission is to research and develop novel pharmaceuticals, which protect and repair tissue and organ damage caused by disease, trauma, or other pathology. RegeneRx Biopharmaceuticals is headquartered in Rockville, Maryland.

The Company holds manifold issued patents or filed patent applications worldwide to enable and protect numerous indications and applications for its product candidates. At present, RegeneRx has three drug candidates in clinical development for ophthalmic, cardiac, and dermal indications.

Furthermore, the Company has three active strategic licensing agreements in the U.S, China, and Pan Asia (Korea, Japan, and Australia, among others). In addition, RegeneRx has patents and patent applications covering its products in many nations globally.

RegeneRx Biopharmaceuticals is concentrating on moving three distinct Tβ4-based drug candidates through the clinic. These are RGN-137, RGN-259, and RGN-352. RGN-137 is a topical gel formulation of the peptide Tβ4. The Company is developing this as a novel treatment to expedite dermal healing. RGN-137 is a Tβ4-based dermal gel formulation undergoing development for epidermolysis bullosa, which is a rare skin condition.

RegeneRx Biopharmaceuticals is focusing on the development of Thymosin beta 4 (a novel therapeutic peptide), for tissue and organ protection, repair and regeneration. RGN-259, its TB4-based ophthalmic drug candidate, has been designated an orphan drug for the treatment of neurotrophic keratopathy (NK), which is a primary focus of RegeneRx’s clinical development efforts in the U.S.

RegeneRx is also developing RGN-352. RGN-352 is its TB4-based injectable. This is a Phase 2-ready drug candidate designed to be administered systemically to prevent and repair cardiac damage resulting from heart attacks and central nervous system tissue damage associated disorders. These include peripheral neuropathy, multiple sclerosis and traumatic brain injuries - including stroke.

This past November, RegeneRx Biopharmaceuticals announced that Thymosin beta 4 (Tβ4), the active ingredient in RGN-259, a preservative-free ophthalmic eye drop, was the subject of a Keynote Address at the 5th International Symposium of Thymosins in Health and Disease in Washington, DC. The presentation was given by Dr. Gabriel Sosne, an award-winning clinician scientist, Associate Professor in Ophthalmology and Anatomy and Cell Biology at Wayne State University School of Medicine, and a clinician at the Kresge Eye Institute in Detroit, Michigan.

RegeneRx Biopharmaceuticals, Inc. (RGRX), closed Friday's trading session at $0.179, up 5.29%, on 8,200 volume with 6 trades. The average volume for the last 3 months is 47,024 and the stock's 52-week low/high is $0.139/$0.305.

chart

Abattis Bioceuticals Corp. (ATTBF)

Greenbackers, Stockgoodies, Cannabis Financial Network News, PennyStocks24, Promotion Stock Secrets, InvestorIntel, CFN Media Group, Goldman Small Cap Research, and Information Solutions Group reported earlier on Abattis Bioceuticals Corp. (ATTBF), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Abattis Bioceuticals Corp. is a life sciences and biotechnology company listed on the OTC Markets. Abattis aggregates, integrates and invests in cannabis technologies and biotechnology services for the legal cannabis industry developing in Canada. It has successfully developed and licensed natural health products, medicines, extractions, and ingredients for the biologics, nutraceutical, bioceutical, and cosmetic markets. Abattis Bioceuticals is headquartered in Vancouver, British Columbia (BC). The Company has an operations office in Langley, BC.

Abattis’ brands include Northern Vine Labs™ and Vergence Naturals™. The Company is also working to acquire exclusive intellectual property (IP) rights to agricultural technologies to be used in the extraction and processing of botanical ingredients and compounds. Abattis has, via its operations and wholly-owned subsidiaries, a wide spectrum of capabilities. These include cultivating, licensing and marketing proprietary ingredients, bio-similar compounds, patented equipment and consulting services to medicinal marijuana markets in North America.

Abattis has a Federally Licensed Testing Lab. Its Northern Vine Labs holds a controlled substance dealers license from Health Canada. Northern Vine Labs' product formulation specialists can create and consult on custom developed products. Additionally, Abattis has exclusive distribution rights to sell and service an industrial scale and cost-effective extraction technology.

Abattis Bioceuticals has completed its acquisition of a 90 percent ownership interest in Gabriola Green Farms, Inc. Gabriola is a BC company. Gabriola has applied for a license to produce (LP) under the Access to Cannabis for Medical Purposes Regulations (ACMPR) on Gabriola Island, one of the gulf islands in the Strait of Georgia off the coast of BC. At present, Gabriola has plans for a roughly 26,000 square-foot production facility to produce medical-grade marijuana situated on 18 acres in the agricultural land reserve on Gabriola Island, BC. Abattis Bioceuticals announced this past July that it entered into a definitive agreement with Emerald Health Therapeutics, Inc. to dispose of its 35 percent interest in Northern Vine Canada, Inc. in exchange for $2 million in cash and $4 million in freely tradeable common shares of Emerald Health Therapeutics.

In connection with the Agreement, Abattis entered into a Master Services Agreement with Northern Vine to provide for Abattis’s continued use of Northern Vine’s laboratory as a “preferred customer”. This includes Abattis’s development work on a hemp-infused cannabinoid-rich, THC-free craft beer with Faculty Brewing Co. and on nanoemulsified and liposomal platforms for transmucosal delivery of cannabinoid-rich hemp oil with the University of British Columbia.

Also, in July, Abattis Bioceuticals announced that it closed its investment in XLABS Therapeutics (ONT), Inc. Abattis and XLABS will be launching a new cannabis laboratory in Belleville, Ontario, to serve Ontario’s rising cannabis sector. Moreover, in August it was reported that Emerald Health Therapeutics completed the purchase of the remaining shares of Northern Vine Canada, Inc. from Abattis Bioceuticals. The transaction increases Emerald’s ownership of Northern Vine from 65 percent to 100 percent.

In October, Abattis Bioceuticals announced that the research taking place in conjunction with the University of British Columbia and Mitacs is close to completing their phase of testing. Abattis announced in Q1 2018 a research study in partnership with Mitacs to explore the development of nanoemulsified and liposomal platforms for transmucosal delivery of cannabinoid-rich hemp oil. The R&D work has been led by scientists from Abattis Bioceuticals and the Faculty of Land and Food Systems at the University of British Columbia (UBC).

Abattis Bioceuticals Corp. (ATTBF), closed Friday's trading session at $0.1036, up 6.02%, on 669,742 volume with 136 trades. The average volume for the last 3 months is 1,444,604 and the stock's 52-week low/high is $0.075/$0.744.

chart

DXI Energy, Inc. (DXIEF)

Stockfuse, Dividend Investor, Stockhouse, Private Capital News Wire, Marketwired, YCharts, and Amigo Bulls reported earlier on DXI Energy, Inc. (DXIEF), and today we report on the Company, here at the QualityStocks Daily Newsletter.

DXI Energy, Inc. is a tactical acquisitor and developer of strategic energy resources. The Company is an upstream oil and gas exploration and production business. DXI Energy operates in Colorado’s Piceance Basin and in the Peace River Arch area in British Columbia (B.C.). DXI Energy has offices in Calgary, Alberta, and Vancouver, British Columbia. The Company lists on the OTC Markets Group’s OTCQB.

In Colorado’s Piceance Basin, DXI Energy has 24,407 net acres. In the Peace River Arch region in B.C. it has 13,093 net acres. Pertaining to its project areas, in the Piceance Basin in northwest Colorado, it has its Kokopelli project with 12 producing wells with extensive in place infrastructure to supplement future development as product prices dictate.

The Company’s land holdings in the Piceance Basin highlight potential long-term regional resource value. This is as utilities develop sources of natural gas. For Kokopelli, DXI Energy retains a 25 percent Working Interest (WI) in 2,200 acres (550 net, 2 leases).

In addition, the Company has its Roan Creek project (West Piceance Hi-Pressure Mancos/Niobrara Gas). This project is 1,960 net acres, 100 percent WI. There is potential development of 8-10 high pressure Mancos/Niobrara 8200’ vertical/Hz wells. The Woodrush Project in northeastern B.C. encompasses 14,444 net acres (20.701 (gross) with 12 wells (3 oil and gas, 9 natural gas). DXI Energy is the operator. The Company owns 99 percent of this Project.

DXI Energy has a multi-phase plan to expand production and landholdings at the Woodrush Project. It has $13mm invested in production facilities and a related network of pipelines at the Woodrush Project.

Last month, DXI Energy announced the implementation of operational enhancements by the new project operator designed to considerably improve production efficiency at the Kokopelli gas/liquids field. Through taking advantage of existing facilities nearby, owned by operator TEP of Houston, Texas, and spreading the Kokopelli operational costs over a large number of production wells, the operator is significantly lessening or eliminating key current expenses associated with Kokopelli. This includes labor, supervision, as well as chemical costs. Therefore, DXI Energy expects to experience a Net Revenue improvement of roughly 100 percent for its present United States production profile.

DXI Energy, Inc. (DXIEF), closed Friday's trading session at $0.0293, up 33.18%, on 11,200 volume with 2 trades. The average volume for the last 3 months is 88,058 and the stock's 52-week low/high is $0.0104/$0.1316.

chart

Flexpoint Sensor Systems, Inc. (FLXT)

Tip Ranks, MarketWatch, Investors Hub, Uptick Newswire, Super Stock Screener, Equity Clock, Business Insider, The Street, Stockhouse, Simply Wall St, Investopedia, Investing, Research and Markets, Marketbeat, and Investor Place reported on Flexpoint Sensor Systems, Inc. (FLXT), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Flexpoint Sensor Systems, Inc. is a technology company specializing in developing products that feature its patented Bend Sensor® and related technology. The Bend Sensor's single-layer, thin film construction decreases costs and mechanical bulk. It does so while introducing a range of functions and stylistic design possibilities, which have never before been available in sensing technology. Flexpoint Sensor Systems is headquartered in Draper, Utah.

The Bend Sensor® product consists of a coated substrate, such as plastic, that changes in electrical conductivity as it is bent. Electronic systems connect to the sensor and measure with fine detail the amount of bending or movement that occurs. The single layer design of the Bend Sensor® eliminates many of the problems associated with conventional sensors. This includes dust, dirt, liquids, and also heat and pressure effects.

Flexpoint produces the Bend Sensor® for numerous applications, covering many markets. These markets include automotive and transportation, wearables, medical, industrial controls, consumer products, and toys/gaming. The Company offers Consulting, Design, Development, and Manufacturing related to the adoption of the Bend Sensor® technology.

Since early in 2017, Flexpoint Sensor Systems and CaptoGlove® began a strategic, collaborative relationship to deliver inventive, integrated virtual reality/augmented reality (VR/AR) systems driven by Bend Sensors® to mass markets. Flexpoint continues its wide-ranging success in the Virtual Reality/Augmented Reality (VR/AR) market for Glove-Based Systems.

Flexpoint Sensor Systems announced in June 2018 two significant development opportunities.  The opportunities involve the implementation of two of the Company’s Bend Sensor® technologies for vehicles, and the development of its Bend® Sensor technology and its testing and proof of concept for tracking and monitoring the use of opioids.

The Company is working with two major U.S. Automotive manufacturers on its seat occupancy sensor technology and pedestrian impact sensor system. In addition, Flexpoint has been working and collaborating with another company to adapt and use the Bend Sensor® Technology in a system configuration that will permit the healthcare industry to effectively track and monitor the usage of opioids on a real-time basis.

In October, Flexpoint Sensor Systems announced that it finalized a Manufacturing and Supply agreement that will give exclusive manufacturing and supply of sensors to Counted LLC for delivery to selected and established end users. The five-year agreement calls for Flexpoint’s patented process, featuring the Bend Sensor® Technology, to be integrated into a system conceptualized by Counted that provides a mechanism for the tracking of medications and digital distribution of data. The data from the device can be transmitted to pharmaceutical companies, insurance companies, patients, healthcare providers, law enforcement or the government health care system.

Clark Mower, Flexpoint Sensor Systems’ Chief Executive Officer, said, “The technology is readily transferable to an expanded number of additional products and applications. Flexpoint’s Bend Sensor® technology will be used in a system configuration that will allow the healthcare industry to effectively track and monitor the usage of medications on a real-time basis. Prototype production, testing, and proof of concept testing have already been successfully completed with positive results.” 

Flexpoint Sensor Systems, Inc. (FLXT), closed Friday's trading session at $0.075, up 0.27%, on 16,500 volume with 5 trades. The average volume for the last 3 months is 172,012 and the stock's 52-week low/high is $0.0322/$0.1199.

chart

Integrity Applications, Inc. (IGAP)

Stockflare, Morningstar, Market Exclusive, Wallmine, Market Screener, OTC Markets Group, Wallet Investor, MarketWatch, Stockopedia, SmallCapVoice, and Capital Cube reported previously on Integrity Applications, Inc. (IGAP), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.

Integrity Applications, Inc. is the maker of GlucoTrack®. This is a non-invasive device for measuring glucose levels in people with type 2 diabetes and pre-diabetes. GlucoTrack® is a monitoring device that quickly measures and displays an individual's glucose level in about a minute without finger pricking or any pain. Integrity Applications has its corporate office in Wilmington, Delaware. The Company has a research and development (R&D) site in Ashdod, Israel.

Integrity Applications is focusing on three important initiatives - GlucoTrack Commercialization in Europe; GlucoTrack U.S. FDA (Food and Drug Administration) Approval; and a Product Roadmap. Its initial principal emphasis is on the commercialization of GlucoTrack in Europe. GlucoTrack® has received CE Mark and KFDA approvals for type 2 diabetes and pre-diabetes. It is now in the early stages of commercialization in Europe, South Korea, and other geographies.

GlucoTrack® features a small sensor. The sensor clips to the earlobe and measures the user's glucose level using innovative and patented sensor technology. The measured signals undergo analysis using a proprietary algorithm and then a calculated glucose level is displayed on a small handheld device the size of a small mobile phone.

The glucose results are stored in the device and used to project an estimated HbA1c level using a proprietary algorithm. Moreover, the device can display glucose values graphically, enabling the user to monitor glucose levels over time. GlucoTrack® is currently experimental in the United States. It is limited to investigational use only.

This past August, Integrity Applications announced that it received its first order from CuraTec Nordic, its exclusive distributor for the Nordic Countries. The commercialization of GlucoTrack® in Europe is one of Integrity Applications’ near-term priorities. The Company earlier signed a distribution agreement for the Netherlands, and by way of its distributor was in discussions with local insurance companies for reimbursement of GlucoTrack®.

Mr. David Podwalski, Integrity Applications’ Chief Commercial Officer, said in August, “We are encouraged by the quick progress being made with CuraTec Nordic. We strongly believe that our partnership with CuraTec Nordic will allow many diabetics and pre-diabetics in the Scandinavian markets to take advantage of the many benefits of GlucoTrack®.”

Integrity Applications, Inc. (IGAP), closed Friday's trading session at $0.50, even for the day. The average volume for the last 3 months is 1,636 and the stock's 52-week low/high is $0.40/$4.50.

chart

IronClad Encryption Corporation (IRNC)

The Street, Simply Wall St, MarketWatch, 4-Traders, PennyStockHub, InvestorsHub, OTC Markets, YCharts, Barchart, Investors Hangout, Stock News Now and TradingView reported on IronClad Encryption Corporation (IRNC), and today we report on the Company, here at the QualityStocks Daily Newsletter.

IronClad Encryption Corporation is a next-generation cyber defense company listed on the OTCQB. Its strategic and tactical data protection solutions strengthen existing encryption methods. The Company’s technology can provide continuous authentication of encrypted data transmitted, creating much stronger defenses to most hacker attacks. IronClad Encryption is based in Houston, Texas.

IronClad Encryption-powered solutions use the Company’s patented Dynamic Encryption and Perpetual Authentication technologies to make all known key-based encryption technologies almost impossible to compromise. Dynamic Encryption Technology eliminates vulnerabilities caused by exposure of any single encryption key through continually changing encryption keys and keeping the keys synchronized in a fault-tolerant way.

Dynamic Encryption technology eliminates the single point of failure problem inherent in single-key encryption techniques. The Company’s key management system continuously produces synchronous keys between the sender and receiver. Each key is assigned to a small amount of data. As a result, if a hacker were to access one of hundreds of millions of keys, the amount of data he would obtain would be almost useless.

IronClad Encryption offers its ICEMicro. This is the world’s first context-free and natively-secure container. It enables all developers to take ownership of application data security. Utilizing ICEMicro, any developer can secure communication between containers across diverse scheduling and orchestration platforms, IaaS services, transport-layer security protocols, and on-premises or hybrid environments using Docker-compatible hypervisors.

IronClad Encryption has partnered with Black Pearl Engineering Management, Inc. to co-develop ultra-secure products based on IronClad’s patented ultra-secure cybersecurity algorithms and methodologies. The joint venture (JV) operates under the name "Black ICE". It is initially concentrating on network gateway products. BlackICE Barrier is the first product in a family of BlackICE products. BlackICE Barrier is specifically targeted at enterprises and industrial use cases where data and control systems necessitate the highest level of security.

Recently, IronClad Encryption announced that it entered into an agreement with Charter Trading Corporation enabling Charter to deploy IronClad’s ICEmicro to secure Charter’s cyber transmissions from its Texas headquarters to its operations in Latin America. This deployment of ICEmicro within Charter’s system is a vital part of Charter’s process to attain compliance with the security controls in National Institute of Standards and Technology (NIST) Special Publication 800-171.

On October 17, 2018, IronClad Encryption announced that Layer 3 Communications tested and verified IronClad’s cyber technology used by ICEmicro. Furthermore, Layer 3 Communications is producing a white paper, expected to be published in 30 days, which explains the validation procedures, parameters and results, and also its significance. Layer 3 Communications is an engineering firm providing complex network services and products.

IronClad Encryption Corporation (IRNC), closed Friday's trading session at $0.31, even for the day. The average volume for the last 3 months is 8,716 and the stock's 52-week low/high is $0.05/$8.50.

chart

Isodiol International, Inc. (ISOLF)

OTC Markets, Investopedia, Stockhouse, Wealth Daily, and InvestorsHub reported on Isodiol International, Inc. (ISOLF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Isodiol International, Inc. specializes in the development of pharmaceutical and wellness products. The Company’s growth strategy includes the development of over-the-counter (OTC) and pharmaceutical drugs and expanding its phytoceutical portfolio. Be Trū Wellness is a wholly-owned subsidiary of the Company. Isodiol is continuing global expansion into Latin America, Asia, and Europe. An international CBD innovator, Isodiol International has its head office in Vancouver, British Columbia.

The Company specializes in hemp-based health and wellness products and the development of pharmaceutical CBD delivery methods. Furthermore, Isodiol specializes in the manufacturing of a pure, natural CBD as an Active Pharmaceutical Ingredient (API) for use in finished pharmaceutical products (FPPs).

Isodiol is the market leader in pharmaceutical grade phytochemical compounds. Additionally, it is the industry leader in the manufacturing and development of phytoceutical consumer products. The Company produces raw ingredients, consumer packaged goods, including dietary supplements, food and beverages, skin care, and pharmaceutical products for the global healthcare market. Concerning consumer products, it develops its own family of product brands for retail sale.

Pertaining to raw ingredients, Isodiol develops natural phytoceutical derivatives and delivery technologies. It also develops white label products and brands for wholesale customers. Regarding pharmaceuticals, Isodiol supplies raw phytoceutical ingredients.

Isodiol International has acquired international licensing rights for IsoDerm™ and five other proprietary pharmaceutical compounds to be delivered by the patented Direct Effects Technology™. This is a back of the neck delivery system from its developer Dr. Ronald Aung-Din, MD.

Isodiol also has its ImmunAG™. This product is the market’s first non-cannabis cannabidiol (CBD) product derived from the hops plant. This is a time-released tablet. The ImmunAG tablet does not dissolve in the stomach. It dissolves in the lower intestine, consequently creating greater bioactivity.

Last month, Isodiol International provided an update on its recently acquired Florida based bottler, Azure. The Company is planning for increased warehousing capabilities and expansion of the production facility in Leesburg, Florida. IsoBev is Isodiol’s division that centers on growing its beverage brand portfolio and contract manufacturing services for the beverage industry. With the expansion of the Leesburg warehouse, the Company will be able to facilitate its distribution needs in the Southeast market and provide Azure additional space to boost production for its customers, which include Sysco, McArthur Dairy and Dean Foods.

Isodiol International, Inc. (ISOLF), closed Friday's trading session at $1.6064, up 25.61%, on 148,054 volume with 224 trades. The average volume for the last 3 months is 120,006 and the stock's 52-week low/high is $1.195/$16.89.

chart

Leafbuyer Technologies, Inc. (LBUY)

Market News Updates, Business Wire, Stockwatch, Barchart, MarketWatch, InvestorsHub, Daily Marijuana Observer, Stockhouse, GuruFocus, Insider Financial, and OTC Markets reported on Leafbuyer Technologies, Inc. (LBUY), and we also report on the Company, here at the QualityStocks Daily Newsletter.

Leafbuyer Technologies, Inc. is a top cannabis technology platform. Leafbuyer is one of the most comprehensive online sources for searchable cannabis deals, specials, and menus. Leafbuyer is the official marijuana deals platform of Voice Media Group, Grasscity, Dope Media and LA Weekly. Leafbuyer Technologies is headquartered in Greenwood Village, Colorado. The Company’s shares trade on the OTC Markets’ OTCQB.

Leafbuyer Technologies’ online network reaches millions of marijuana consumers monthly. The Company continues to expand into every legal state. It is working to be the ultimate cannabis resource, providing consumers and businesses with the resources they require to succeed in the cannabis industry.

Leafbuyer.com connects consumers with dispensaries. The Company works alongside businesses to highlight their unique products and build a network of loyal patrons.

Leafbuyer Technologies has launched Leafbuyer TV. Leafbuyer TV includes television news style segments to complement and enhance the Leafbuyer.com News and Blog section of its website, and also the Company’s social media platforms. This TV service is free to the public.

Phase Two of Leafbuyer Technologies’ advanced large-scale platform based on blockchain technology has started. Working with its select specialists, Wunderkind Technologies, LLC, the second strategic phase has started to reliably verify transactions with dispensaries. Blockchain will allow Leafbuyer Technologies’ systems management team to accurately, in real time, verify referrals, customer traffic, point-of-purchase, pricing and a broad number of proprietary data points for the Company’s clients.

In late August, Leafbuyer announced it is the first major cannabis technology platform to combine all three major advertising initiatives for legal dispensaries into one offering, named “The Ultimate Bundle.” Available immediately, the innovative package combines three core marketing tools. These are consumer attraction tools (directory listings), a strong texting and loyalty platform, and online ordering.

Yesterday, Leafbuyer Technologies announced the implementation of its own, enterprise-level loyalty platform named “Leafbuyer Loyalty”. This program will eventually fully integrate with the Company’s blockchain and order-ahead initiatives.

Mr. Mark Breen, Leafbuyer Technologies’ Director and Chief Operating Officer, said, “By rolling out our own loyalty platform, we will have more control to develop and adapt to the ever-changing needs of our customers. Up to this point, we’ve worked through a third-party revenue sharing agreement to provide texting/loyalty. With the launch of our new system, we will save these expenditures and add to our bottom line.”

Leafbuyer Technologies, Inc. (LBUY), closed Friday's trading session at $1.00, up 2.04%, on 140,648 volume with 173 trades. The average volume for the last 3 months is 449,558 and the stock's 52-week low/high is $0.551/$3.15.

chart

The QualityStocks Company Corner

First Cobalt Corp. (TSX.V: FCC) (OTC: FTSSF)

The QualityStocks Daily Newsletter would like to spotlight First Cobalt Corp. (FTSSF).

Vertically integrated North American pure-play cobalt company First Cobalt (TSX.V: FCC) (OTCQX: FTSSF) (ASX: FCC) recently reported the results of its first NI 43-101 Mineral Resource Estimate for its wholly-owned Iron Creek Cobalt Project in Idaho. FTSSF reported Inferred Mineral Resources of 29.6 million tons (26.9 million tonnes) grading 0.11 percent cobalt equivalent, under a base case scenario, and an alternative underground-only scenario indicating 4.9 million tons (4.4 million tonnes) grading 0.30 percent cobalt equivalent (http://nnw.fm/Af2zz). To view the full article, visit: http://nnw.fm/ON4aq.

First Cobalt Corp. (TSX.V: FCC) (OTC: FTSSF), with headquarters in Canada, is the largest land owner in the Cobalt Camp in Ontario with control of over 10,000 hectares (nearly 25,000 acres) of prospective land and 50 historic cobalt/silver mines. The company’s assets include a mill and the only permitted cobalt extraction refinery in North America capable of producing battery material, providing an integrated solution for cobalt projects. First Cobalt began drilling in the historic Cobalt Camp in 2017 and seeks to build shareholder value through new discovery and growth opportunities.

First Cobalt’s 2018 $C7 million drilling program, which includes testing different styles of mineralized areas throughout the Cobalt Camp in more than 10 past-producing mines known to contain cobalt, is a significant expansion over its 2017 exploration activities. The company received positive test drill results from the Bellellen mine location, with early results confirming the presence of high-grade cobalt and nickel, prompting First Cobalt to increase its drilling program at that site. A prospecting sampling program of existing muckpiles around the camp’s historic mines, trenches, pits and surrounding bedrock could provide an early production scenario.

First Cobalt Corp. is moving quickly to leverage its potential against an economic background that estimates global consumption for refined cobalt is set to grow at an average rate of approximately 5 percent per annum for the next 10 years. The electric vehicle market, in particular, is driving this sector since more than 50 percent of the world’s current production of cobalt is used in the manufacture of rechargeable lithium-ion batteries. The global lithium-ion battery market, as estimated by Zion Market Research, indicates the value at around USD $31 billion in 2016 and is expected to generate revenue of nearly USD $68 billion by end of 2022, growing at a compound annual growth rate of slightly above 17 percent.

First Cobalt is embracing innovation in the mining sector, utilizing a digital compilation of 100-plus years of mining and geological data spanning the historically prolific Cobalt Mining Camp’s lifespan. First Cobalt’s management team is also assessing the ability of artificial intelligence to accelerate the discovery cycle. As a member of the Mineral Exploration Research Centre (MERC) and Metal Earth Project, First Cobalt conducts regional geophysical surveys for geological interpretation of structures controlling cobalt-silver mineralization.

The company’s clear pathway to production and cash flow generation includes being one of only four fully permitted cobalt extraction refineries in Canada with significant material and processing infrastructure on site. With the price of cobalt increasing significantly and its importance in the growing battery market underpinning a strong long-term demand forecast, First Cobalt Corp. and its mining interests are primed for success.

First Cobalt Corp. President and CEO Trent Mell, a mining executive and capital markets professional with extensive international transactional experience, is joined by a team of reputable and seasoned deal-makers, mine builders and mine operators with decades of global experience in exploration, business development, geoscience, engineering and finance.

First Cobalt Corp. (FTSSF), closed the day's trading session at $0.1628, up 12.20%, on 516,405 volume with 68 trades. The average volume for the last 3 months is 213,488 and the stock's 52-week low/high is $0.1382/$1.3041.

Recent News

chart

Lexaria Bioscience Corp. (CSE: LXX) (OTC: LXRP)

The QualityStocks Daily Newsletter would like to spotlight Lexaria Bioscience Corp. (LXRP).

A drug delivery platform pioneer, Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) has developed and out-licenses its DehydraTECH technology. The company’s technology changes the way in which edible cannabinoids absorb into the body. The DehydraTECH drug delivery platform is patented for cannabidiol and all other non-psychoactive cannabinoids and enables the transportation of bioactive substances via oral ingestion. A research-driven enterprise, Lexaria Bioscience is based in Kelowna, British Columbia.

Lexaria Bioscience Corp. (CSE: LXX) (OTC: LXRP) has developed and out-licenses its proprietary technology for improved taste, rapidity, and delivery of bioactive compounds, including cannabinoids. Though boasting a wide range of health benefits, cannabinoids are traditionally poorly absorbed by the body’s gastrointestinal tract. To achieve higher effectiveness, consumers usually default to smoking. Lexaria provides a superior administration method by delivering hemp oil ingredients – or through locally licensed partners, cannabis oil ingredients – through a patented process within food products.

The key differentiator between Lexaria’s products and others on the market is the company’s disruptive technology proven to enhance the absorption of orally ingested cannabinoids while improving the “unusual” taste of cannabinoids and allowing for lower overall dosing with higher efficacy. Lexaria is primarily a B2B enterprise, and is in licensing discussions or has existing agreements with companies in Canada, the largest-market states in the USA, and internationally. Lexaria has also developed its own brands partly for demonstration purposes, utilizing its patented technology to infuse hemp oil ingredients within lipids in popular foods. These brands include ViPova™, Lexaria Energy Foods, and TurboCBD™.

In 2015, Lexaria commissioned an independent, third-party lab to test its technology under carefully monitored in vitro conditions. Results showed that the company’s technological process and lipid formulation both improve intestinal absorption as much as 500%. Additional follow-up studies in human volunteers suggested that Lexaria’s processed, lipid-infused tea may be more effective in an actual gastrointestinal system than in an in vitro simulation with results indicating as much as a 1,000% increase in overall absorption.

Lexaria also has an R&D partnership with the Canadian government’s National Research Council. That R&D is expected to characterize molecular bond formation theorized to occur with Lexaria’s unique technology between the lipid delivery agents and the bioactive substances it processes and combines. Results from this R&D are expected to support accelerating B2B relationships – not just in the cannabis industry, but also to support new B2B business relationships in the fields of vitamins, NSAIDs, and nicotine delivery. All of these sectors expected to offer additional future growth potential.

Aside from testing, a critical component of Lexaria Bioscience’s business model is a strong intellectual property portfolio that utilizes the most commonly used food processing techniques. As of 2017, the company’s patent portfolio includes 19 patent applications filed and pending in more than 40 countries around the world. The most recent patent applications expand Lexaria’s lipophilic food and beverage composition claims to include the processing of cannabinoids, vitamins, NSAIDs and nicotine in many of the world’s most commonly used food processing ingredients. Lexaria is expecting additional new patent awards both in the USA and internationally in 2017 and 2018.

Royalties play a vital role in Lexaria’s revenue-generating business model. The company out-licenses its technology (royalty) to third party partners, and has several deals signed and/or pending. The company’s growth initiatives are guided by a management team headed by CEO Chris Bunka, a serial entrepreneur who has raised more than $50 million in working capital for the companies he has led over the course of his career. He is supported by a team of professionals with extensive experience in pharmaceutical and bioscience sectors, invention, toxicology, consumer goods, and other relevant skillsets.

Lexaria Bioscience Corp. (LXRP), closed the day's trading session at $1.46, up 8.96%, on 123,484 volume with 173 trades. The average volume for the last 3 months is 245,892 and the stock's 52-week low/high is $0.469/$2.539.

Recent News

chart

The Flowr Corporation (TSX.V: FLWR)

The QualityStocks Daily Newsletter would like to spotlight The Flowr Corporation (FLWR).

The Flowr Corporation (TSX.V: FLWR) was highlighted on View from the C-Suite’s video interview series, which highlights the unique perspectives of listed companies on Toronto Stock Exchange and TSX Venture Exchange. https://www.youtube.com/watch?v=f3y9fQj9gUQ. Also, the company was featured in a research report recently by Clarus Securities and then highlighted in an article that discusses the report. To view the full article, visit: http://nnw.fm/a2Fmt.

The Flowr Corporation (TSX.V: FLWR), a Health Canada Licensed Producer (LP) of cannabis under the Access to Cannabis for Medical Purposes Regulations (ACMPR), is an emerging Canadian cannabis leader founded by Medreleaf co-founder Tom Flow and a team of industry pioneers, successful start-up executives and top industry scientists. Flowr’s purpose-built cultivation facilities may be the most advanced in the industry, consistently generating high crop yields, delivering premium and ultra-premium cannabis products, and maximizing return on investment. The company also may be an R&D leader as it was selected by the Hawthorne Gardening Division of The Scotts Miracle-Gro Company as its exclusive Canadian cannabis R&D partner.

Flowr’s flagship facility, an 84,000-square-foot campus on seven acres in Kelowna, British Columbia, is engineered to grow premium cannabis in rooms that meet pharmaceutical industry production standards for cleanliness. This, along with exacting protocols designed by the Flowr team, enables Flowr to grow cannabis that meets Health Canada’s stringent standards without treating it with the taste- and smell-killing gamma irradiation that most other producers have to use to clean their product. Irradiating the plant – a process similar to pasteurizing food – impairs many of the important terpenes that provide the positive effects, flavors and scents of cannabis while strengthening unpleasant terpenes. Flowr’s products may deliver a better user experience, thus commanding premium prices.

Flowr’s cultivation facilities, built with proprietary, patent-pending systems, are designed to deliver yields targeted at 450 grams per square foot by the end of 2022, which is three times more efficient than the industry average of approximately 150 grams per square foot. By optimizing yield, the Company may produce significantly more cannabis flower on a smaller footprint than other producers, thus generating far high revenue per square foot and keeping costs much lower, leading to higher margins. The Kelowna facility is presently 20 percent operational with the remaining 80 percent slated to come online by early 2019. It is expected to produce up to 14,000 kg of premium, non-irradiated cannabis flower in 2019. With further enhanced yields and planned expansion of production facilities on the campus, Flowr will reach a total capacity of 60,000 kg annually in 2022.

Leading Flowr’s cultivation program is industry pioneer, company co-founder and Flowr president Tom Flow. Flow is widely recognized for his cannabis thought leadership and expertise building and operating cannabis cultivation facilities. Flow also co-founded MedReleaf and designed, built and set up SOPs for their flagship Marcum cultivation facility. Marcum has continued to be perhaps the most productive facility in the country prior to the Flowr flagship facility. Long one of Canada’s most efficient and profitable LPs, MedReleaf was acquired by Aurora for approximately C$3 billion. Flow and his team have designed and built a total of 17 cultivation facilities and secured three producer’s licenses under various Canadian regulatory regimes.

In March 2018, Flowr and the Hawthorne Gardening Division of The Scotts Miracle-Gro Company – a world leader in lawn and garden products – announced an exclusive strategic R&D alliance. After evaluating numerous Canadian LPs, Hawthorne chose to partner with Flowr based on the experience and expertise of the company’s cultivation and R&D teams and the company’s advanced growing capabilities.

Hawthorne will fund the construction of a 50,000-square-foot R&D facility that is integrated into Flowr’s Kelowna campus. This facility is North America’s first dedicated cannabis R&D facility focused on advancing cultivation techniques and systems. The facility will support researchers from both organizations and combine laboratories, indoor and greenhouse grow suites, training areas and genetics breeding areas in a single building. It is expected to open in early 2019. In addition to helping Flowr maintain its competitive advantage in cultivation, the company’s R&D program will keep it on the cutting edge of cannabis innovation.

Flowr is entering the market with three different brands to meet the growing demand for premium, non-irradiated cannabis in the medicinal and adult use markets:

  • FlowrRx, featuring premium quality medicinal cannabis that enables patients to live better, fuller lives. A dedicated Client Services team will provide patients with personalized support while an R&D team develops innovative flower strains and premium products targeted to specific conditions. Patient well-being is considered at every stage of the process – from genetic selection to harvest, trimming and curing techniques. FlowrRx and its team of passionate scientists and leading cultivation specialists are dedicated to advancing the scientific understanding of cannabis.
  • Flowr is the company’s premium recreational adult-use brand featuring an active, West Coast-inspired lifestyle for the cannabis connoisseur and enthusiast market. Through the continuous innovation of procedures and practices, Flowr’s talented team of experts is crafting premium products that deliver unparalleled experiences.
  • Ace Valley, an exclusive partnership with top-selling Ontario craft beer company Ace Hill, will bring Flowr’s premium product to the millennial and casual adult-use markets under the Ace Valley brand.

Flowr recently signed a Memorandum of Understanding with the British Columbia Liquor Distribution Branch, the province’s sole legal wholesaler of non-medical cannabis, to supply premium and ultra-premium flower to the province’s retail outlets. The company has agreements with several major medical distributors and is in discussions about retail distribution with additional provinces where it believes it can obtain prices commensurate with the quality of the Flowr products. The company is also evaluating other market opportunities including export.

Flowr is poised to become the pre-eminent indoor premium cannabis grower in Canada and one of the country’s top five LPs. The company’s focus on yield, quality and price point and its team’s ability to grow at scale should drive high margins, significant growth and strong return on investment.

The Flowr Corporation (TSX.V: FLWR), closed the day's trading session at $3.66, up 3.98%, on 63,403 volume with 97 trades. The average volume for the last 3 months is 156,523 and the stock's 52-week low/high is $3.11/$8.00.

Recent News

chart

Phivida Holdings Inc. (CSE: VIDA) (OTC: PHVAF)

The QualityStocks Daily Newsletter would like to spotlight Phivida Holdings Inc. (PHVAF).

Hemp-cultivated cannabinoid innovator Phivida Holdings (CSE: VIDA) (OTCQX: PHVAF) announced the appointment of its new Senior Vice President, Distribution Greg McCauley. McCauley’s experience spans over 30 years in the consumer products industry, serving in roles with major brands including Jägermeister, Muscle Milk and Red Bull. To view the full press release, visit: http://nnw.fm/DHz1f.

Headquartered in Vancouver, Canada, with operations offices in southern California, Phivida Holdings Inc. (CSE: VIDA) (OTC: PHVAF) is a premium food and beverage company that develops CBD-infused functional foods, beverages and supplements poised for global distribution. All products in the Phivida label are infused with organic, hemp-derived cannabinoids into a variety of premium foods, beverages and clinical products for everyday health. Phivida is guided by a team of Fortune 500-caliber executives focused on a new strategic portfolio of products and brands, comprehensive consumer research, new product and brand development, improved visual identity and packaging design, and a strong distribution strategy.

The company’s motto – “Celebrating Health and Wellness, in Harmony™” – underscores Phivida’s mission to lead the alternative health care sector as the benchmark standard in premium CBD-infused functional beverages and tinctures. To execute this goal, Phivida is taking advantage of positive legislative developments in the United States and has defined an elevated national route-to-market strategy across the U.S. where small regional distributors will be now be replaced with large national distributors.

Management

Phivida’s management team includes president and CEO Jim Bailey, former president of Red Bull Canada and global chief marketing officer for Merrell Outdoors; Chief Marketing Officer Michael Cornwell, former chief marketing officer for Samsung New Zealand and the former director of marketing for Red Bull Canada; and Doug Campbell, former director of sales for Red Bull North America, who as Phivida’s chief commercial officer is tasked with driving new sales revenue growth.

Publicly traded on the Canadian Securities Exchange (CSE.VIDA) and recently graduated to the OTCQX Best Market in the USA (OTCQX.PHVAF), the company’s strong balance sheet carries CAD$15.7 million with no debt or loans with less than 60 million shares outstanding and the company is now well-capitalized to fun major mainstream distribution with a solid structure poised for long-term growth.

The Science

Using encapsulation technology, Phivida uses full spectrum CBD-hemp oil (rich in naturally occurring phytocannabinoids) converted into a water-soluble delivery format, which enhances delivery and absorption of the cannabinoids into the human body – up to an estimated tenfold.

Encapsulated CBD is infused into functional beverages, food and supplements containing a proprietary blend of phytonutraceuticals studied to target a range of health and wellness conditions. Phivida tests every product for microbials, heavy metals, pesticides, residual solvents, terpenes, and potency to guarantee less than 0.3 percent THC (tetrahydrocannabinol, the chemical compound in cannabis responsible for a euphoric high) is present.

Regulations

Federally legal under the 2014 Farm Bill, CBD from Hemp Oil is a rapid growth market across the USA. When derived from marijuana, CBD remains a schedule one controlled substances, giving hemp derived CBD oil infused products a competitive advantage on regulations. On June 28, 2018, the U.S. Senate passed the Agriculture Improvement Act of 2018 (i.e. the “Farm Bill), lifting the USA Industrial Hemp laws to an agricultural commodity status and effectively removed hemp from the controlled substance list.

Earlier this year, another milestone court ruling also provided significant regulatory support for the US CBD-Hemp sector. In February 2018, the Supreme Court preceded over the HIA (Hemp Industry Association) vs. DEA (Drug Enforcement Agency) in a class-action suit concerning the issue of CBD extracted from hemp, and the legality of industrial hemp. In the final ruling the Supreme Court unequivocally determined that – when produced domestically under the Farm Bill – hemp (and its derivatives) are not a controlled substance.

The Supreme Court ruling also found the Farm Bill (as it relates to hemp) “pre-empts” the Controlled Substances Act. Congress has since exempted Farm Bill hemp from the Controlled Substances Act (CSA) giving the Farm Bill primary jurisdiction over the governance of the CBD-Hemp Oil industry in the USA.

The DEA further conceded it does not “seek to control cannabinoids,” and that only marijuana derived cannabinoids are governed under the Controlled Substances Act. In May of 2018, the DEA issued a formal directive to all federal agencies (e.g. US Customs and Border Patrol) stating that cannabinoids are not controlled substances unless derived from marijuana, and that the “mere presence of cannabinoids” in any product or derivative does not render it a controlled substance. The Supreme Court ruling also resulted in the mediation of a settlement in what is now the third successful HIA vs. DEA suit in over a decade.

In Canada, the Senate approval of Bill C-45 legalized the production, distribution and use of recreation cannabis – with edibles to be added in 2019. The bill will officially become law as of October 17, 2018, creating a legal framework for the production, distribution, sale and possession of cannabis across Canada including cannabinoid-infused beverages.

3 Wholly Owned Subsidiaries

  • Phivida Organics Inc. offers professional-grade, wholesale, whole plant hemp oil extracts made from 100-percent certified organic hemp stalk. Phivida’s hemp oil extracts are CO2-extracted under quality assurance/clinical standards and are third-party lab tested to assure only pharmaceutical grade, cGMP certified, full-spectrum products are produced and available for sale. Phivida Organics produces hemp oil extracts that deliver nano-encapsulated cannabinoids in water soluble formulations designed to be absorbed up to 10 times faster than other oils, providing up to 400 percent bioavailability. Phivida Hemp Oil Vida+ extract products are available now online at www.Phivida.com.
  • Phivida Nutrition blends the best of nature into CBD-infused lifestyle branded beverages including a variety of CBD infused iced teas and CBD infused flavored waters.
  • Phivida Enhanced – Under the VIDA brand, CBD-infused tinctures, capsules and other supplement products are distributed to alternative health care clinics across the USA.

WeedMD-Phivida

Phivida has signed a binding letter of intent to joint venture WeedMD Inc. (TSX-V: WMD) (OTC:WDDMF) (FSE:4WE), a Health Canada federally licensed producer and distributor of medical cannabis, to form a joint venture focused on cannabis-infused beverages. The new joint-venture company, Cannabis Beverages Inc. (“CanBev”), plans to develop a production facility at WeedMD’s state-of-the-art greenhouse facility in Strathroy, Ontario, Canada. CanBev is on track to build and operate the first cannabis-infused beverage production facilities in Canada. The joint venture will focus on manufacturing, marketing and distribution of cannabinoid-infused beverages for the legalized medical and adult-use cannabis markets.

Management from both WeedMD and Phivida are collaborating on design and engineering strategies and site evaluations on a 610,000-square-foot, state-of-the art facility in Strathroy for the development of CanBev. As an emerging certified food grade production plant, the Strathroy facility is an ideal location and comes is equipped with extensive production infrastructure, including 50,000 sq. ft. of food production and packaging area, cold storage, loading docks, and adequate space to expand for future growth.

Strategic Agreements

Phivida Organics has also entered into an agreement to carry out a pharmacokinetic (PK) study on its hemp-derived, nanoencapsulated CBD with Artelo Biosciences Inc. at the University of Nottingham, School of Medicine at the Royal Derby Hospital, England. The study will test encapsulated-CBD on healthy volunteers and measure how fast and how much CBD enters the blood stream after oral consumption with each of the different formulations developed by Phivida Organics.

Phivida has also activated distribution agreements with Asayake Inc. to become one of the first federally approved CBD-infused food and supplement brands in Japan. With first mover status achieved, Phivida now markets to an underserved, yet highly informed population of 127 million patients and practitioners. The supplement market in Japan is estimated at US$10 billion with the overall functional foods market at US$21 billion. The Asia-Pacific region is the fastest growing market for natural plant-based supplements. Phivida now plans to prepare a formal application to Japan’s Consumer Affairs Agency to register the company’s CBD-infused functional food and beverage products for approval under the country’s Food with Functional Claims regime. The functional beverage market in Japan is estimated at US$10.35 billion with a CAGR of 2.5 percent (2015-2025).

Further Information

www.Phivida.com
+1 (844) 744-6646 (ext. #2)
IR@Phivida.com

Phivida Holdings Inc. (PHVAF), closed the day's trading session at $0.5232, up 2.79%, on 26,898 volume with 22 trades. The average volume for the last 3 months is 116,433 and the stock's 52-week low/high is $0.05/$1.80.

Recent News

chart

SinglePoint, Inc. (SING)

The QualityStocks Daily Newsletter would like to spotlight SinglePoint, Inc. (SING).

SinglePoint (OTCQB: SING) was a featured company on this week’s episode of MoneyTV with Donald Baillargeon. To view the full interview, visit: http://nnw.fm/2yT5E. To view the full press release, visit: http://nnw.fm/kFth5.

SinglePoint, Inc. (SING) is a diversified holding company with operations in multiple industries and verticals including two high-performing market sectors: legal cannabis and cryptocurrencies. SinglePoint has grown from a full-service mobile technology provider to a recognizable brand with a diverse portfolio of undervalued subsidiaries with multiple revenue streams.

SinglePoint is researching opportunities where it can be an active participant by influencing the strategy and direction of high-potential companies whose verified assets offer attractive possibilities for shareholders. The company is guided by a visionary leadership team with extensive experience in technology, engineering, marketing and raising capital.

SinglePoint is bullish on the cannabis industry, bitcoin and blockchain technologies, which is evident in its recent acquisitions and joint-venture announcements. Recent SinglePoint key highlights include:

  • A joint venture with Smart Cannabis Corporation (OTC: SCNA) to license and market Smart Cannabis’ SMART APP. SMART APP enables cannabis growers to measure all aspects of cultivation, from soil nutrient levels to watering cycles and carbon dioxide content in the air. SMART APP will integrate SinglePoint’s bitcoin payment solution to enable growers to process safer and more secure transactions.
  • A joint venture with Global Payout (OTC: GOHE) will build on existing financial technology solutions developed by SinglePoint and Global Payout’s subsidiary MoneyTrac Technology, Inc., to fully optimize the delivery of mobile payment applications for domestic and international organizations.
  • A joint venture with AppSwarm (OTC: SWRM) to start development on a proprietary delivery application that will enable licensed cannabis delivery services and licensed dispensaries to safely make in-home cannabis deliveries.
  • Signed original “Shark Tank” member Kevin Harrington as company spokesman for an innovative, compatible virtual wallet to store any type of cryptocurrency. Harrington recently finished shooting a new national ad campaign featuring SinglePoint and the virtual wallet’s secure method of storing cryptocurrencies.
  • Entered into a letter of intent to acquire 100 percent of Bitcoin Beyond, a premier platform that enables merchants to accept bitcoin payments using existing web-enabled point-of-sale devices.
  • Through SING subsidiary, SingleSeed, the company will soon offer a proprietary cryptocurrency solution that links both cannabis merchants and consumers who seek to take advantage of bitcoin-powered transactions using debit and credit cards. In addition to making bitcoin-backed card purchases possible, the solution enables cannabis dispensaries to digitally track and manage their product inventories, performing tasks like uploading product data, photos and descriptions. The system deducts items automatically from a dispensary’s product listings when a purchase is made. While this fully KYC-AML compliant point-of-sale platform can be utilized for any other retail setting, it will fill a critical need in the underbanked cannabis industry as it continues to seek non-cash payment solutions outside of traditional banking circles.

SinglePoint CEO and founder Greg Lambrecht leads the company in its mission to capture opportunities through an aggressive expansion strategy across a broad range of assets. Lambrecht oversees all company operations including investor relations, leadership of the board of directors, and daily business activities. As the founder of PCI, a leading consumer product distribution company, Lambrecht negotiated agreements with the nation’s largest retail outlets and led PCI through a NASDAQ listed IPO, raising $10 million.

Eric Lofdahl, SinglePoint’s chief technology officer, has more than 20 years of experience in the technology sector including positions in software development, program management, complex system integration and engineering process definition. Prior to SinglePoint, Lofdahl worked at the Boeing Company where he led a team that successfully developed advanced wireless and satellite data products based on commercial technology for the U.S. Air Force.

SinglePoint President Wil Ralston is well known for his successful track record of building and maintaining great relationships with clients. Ralston graduated cum laude from the WP Carey School of Business at Arizona State University with a degree in Global Agribusiness and a specialization in Professional Golf Management. He is currently recognized by the Professional Golfers Association of America (PGA) as a Class A Professional.

SinglePoint, Inc. (SING), closed the day's trading session at $0.02668, up 3.41%, on 2,517,198 volume with 123 trades. The average volume for the last 3 months is 4,607,305 and the stock's 52-week low/high is $0.0235/$0.133.

Recent News

chart

TMSR Holding Company (NASDAQ: TMSR)

The QualityStocks Daily Newsletter would like to spotlight TMSR Holding Company (TMSR).

The People’s Republic of China has put solid industrial waste at the top of its anti-pollution agenda, with new laws aimed at requiring companies to implement measures to handle the waste they generate, according to a Reuters report (http://nnw.fm/QcGB8). As a developer and provider of innovative industrial and mining waste management solutions, TMSR Holding Company Limited (NASDAQ: TMSR) is dedicated to offering the mining sector and other industries a means of turning waste into useful materials.

TMSR Holding Company (NASDAQ: TMSR), together with its subsidiaries, is a recognized leader in the research, development, production and sale of solid waste recycling systems and zero emissions process systems, for the industrial and mining sectors in the People’s Republic of China. The company operates through its wholly owned business divisions: Shengrong Environmental and Wuhan HOST Coating Materials.

TMSR’s Shengrong subsidiary designs, builds, sells and services customized solid waste recycling systems and equipment for some of the largest industries in China. The company provides customers full-service, tailor-made systems from conceptual design to planning, production, modernization, optimization, assembly, start-up, conversions, disassembly, maintenance and servicing of components to complete zero emissions solid waste recycling and process systems.

Utilizing what management believed to be the world’s most advanced technologies of physical magnetic industrial solid waste recovery, Shengrong can process a variety of industrial solid waste materials and is able to extract valuable metal byproducts from the waste without generating any chemical pollution. Shengrong’s patented equipment can process aluminum slag, copper mine tailings, iron mine tailings, red mud manganese tailings, and molybdenum tailings among many others. Unlike traditional chemical-based recovery methods, the company extracts resalable metals from the waste without generating any pollution. The residues are processed to manufacture high-quality construction materials, turning polluted solid waste into valuable industrial materials with zero discharge.

Industrial solid waste recycling and heavy metal removal are significant worldwide technical, financial and environmental issues. Through Shengrong, TMSR is addressing this profound unmet market need by delivering end users a clean alternative to traditional waste disposal. The company intends to leverage these serious unmet needs, expand its patented industrial waste recycling systems to broad international markets, and provide global industrial and mining businesses cost-effective, patented green technology platforms that create new-found revenue streams for end users.

Through Shengrong, TMSR owns two U.S. patents and five patents granted by the Peoples Republic of China, including four invention patents and two utility model patents. The company’s research and development efforts have achieved technological advancements that allow end users to eliminate pollutant discharge as well as generate new revenue streams by selling valuable byproducts extracted from industrial waste.

TMSR subsidiary, Wuhan HOST Coating Materials, is the largest manufacturer of inorganic Zinc-rich resin and one-component epoxy Zinc-rich resin in China. Established in 2010, Wuhan HOST is a leader in the research and development, production and sale of Zinc-rich coating materials throughout the PRC and has a broad customer base that includes some of the foremost enterprises in major industries such as electricity, metallurgy, machinery, chemicals, bridge and shipping. TMSR completed the acquisition of 100% equity interest in Wuhan HOST Coating Materials on May 1, 2018.

Notably, TMSR first went public as JM Global Holding Company, a Special Purpose Acquisition Company (SPAC) formed to effect a merger, asset acquisition or other business combination that had exceptional growth potential. After reviewing over 50 potential targets and completing due diligence and third party analysis, JM Global identified China Sunlong Environmental Technology Inc. and its wholly owned subsidiaries as the acquisition target. Upon closing the business combination, the company was re-named TMSR Holding Company Ltd.

Demand for TMSR’s products is expected to grow significantly due to Chinese policies that encourage mining and manufacturing companies to adopt “green” technology. Approximately 3 billion tons of industrial solid waste were generated annually in China between 2011 through 2015.  Currently, 95% of industrial solid waste in China is stored in special facilities and sites; however, the cost of storage, disposal and incineration of industrial solid wastes is high. TMSR is focused on exploiting this unmet need, providing end users in the solid waste recycling markets a clean alternative to traditional waste disposal, significantly reducing solid waste discharge into the environment and enabling end users to extract value from industrial waste materials.

TMSR Holding Company (TMSR), closed the day's trading session at $3.0994, even for the day, on 562 volume. The average volume for the last 3 months is 8,481 and the stock's 52-week low/high is $1.84/$10.32.

Recent News

chart

BriaCell Therapeutics Corp. (OTC: BCTXF) (TSX.V: BCT)

The QualityStocks Daily Newsletter would like to spotlight BriaCell Therapeutics Corp. (BCTXF).

Breast cancer is the second-leading cause of cancer death for U.S. women. Although death rates from this disease have been falling since 1989, still in 2018 nearly 41,000 Americans are expected to die of breast cancer. BriaCell Therapeutics Corp. (OTCQB: BCTXF) (TSX.V: BCT), a biotechnology company developing targeted, safe treatments for cancer, is working on the first personalized off-the-shelf immunotherapy drug for advanced breast cancer.

BriaCell Therapeutics Corp. (OTC: BCTXF) (TSX.V: BCT), based in Berkeley, CA, and headquartered in Vancouver, British Columbia, is a clinical-stage biotechnology company focused on the development of targeted immunotherapy for advanced breast cancer.

BriaCell hopes to develop and market the first off-the-shelf personalized immunotherapy for the treatment of advanced breast cancer.

The results of two previous proof-of-concept clinical trials produced encouraging results in patients with advanced breast cancer. Most notably, one patient with breast cancer that had spread to other sites (metastatic cancer) responded to Bria-IMT™ with a substantial tumor shrinkage in multiple sites including the breast, the lung, soft tissues and even the brain. Similar observations have been confirmed more recently in additional patients, and BriaCell is developing BriaDX™ as a way to identify those patients most likely to respond.

BriaCell has recently completed recruitment of a Phase I/II study (NCT03066947) of Bria-IMT™, the Company’s lead product candidate, in advanced breast cancer patients showing an outstanding safety profile and excellent efficacy. BriaCell is currently enrolling advanced breast cancer patients in a combination therapy trial (NCT03328026) of Bria-IMT™ with Keytruda® (Keytruda® is a registered trademark of Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc.) or Yervoy® (Yervoy® is a registered trademark of Bristol-Myers Squibb Company). For further information on the Phase IIa clinical trials, please visit trial NCT03066947 and trial NCT03328026.

BriaCell’s pipeline also includes Bria-OTS™, the first off-the-shelf personalized immunotherapy for advanced breast cancer; and, a companion diagnostic product BriaDX™. By using BriaDX™ to identify and treat the patients who would most likely benefit from their immunotherapies, BriaCell expects to personalize the treatment for the patients, and bring hope to thousands of cancer patients who currently have few-to-no treatment options.

Breast Cancer Statistics

The National Cancer Institute estimates that more than 265,000 new cases of female breast cancer will be diagnosed in the U.S. during 2018, and that more than 40,000 women in the U.S. will die from the disease. Approximately 12 percent of women will be diagnosed with breast cancer at some point during their lifetime, based on 2013-2015 data.

Using its novel technology platform and strong R&D capabilities, BriaCell believes it has the opportunity to address this market, as well as have the opportunity to develop immunotherapy candidates for other cancer indications.

The global cancer immunotherapy market is expected to reach nearly USD$203 billion by 2025.

BriaCell Therapeutics Corp. (BCTXF), closed the day's trading session at $0.083, even for the day. The average volume for the last 3 months is 18,335 and the stock's 52-week low/high is $0.068/$0.1387.

Recent News

chart

QMC Quantum Minerals Corp. (OTC: QMCQF) (TSX-V: QMC) (FSE: 3LQ)

The QualityStocks Daily Newsletter would like to spotlight QMC Quantum Minerals Corp. (QMCQF).

QMC Quantum Minerals Corp.’s (OTC: QMCQF) (TSX.V: QMC) (FSE: 3LQ) geotechnical field crews recently identified significant spodumene mineralization while evaluating the Irgon Lithium Mine Property, which lies within the prolific Cat Lake-Winnipeg River rare-element pegmatite field. This world-renowned pegmatite field also hosts the nearby Tantalum Mining Corporation of Canada (“TANCO”) pegmatite operation.

QMC Quantum Minerals Corp. (OTC: QMCQF) (TSX-V: QMC) (FSE: 3LQ) is a British Columbia based company engaged in the business of acquisition, exploration and development of natural resource properties. QMC’s focus is on creating shareholder value through strategic acquisition and development of high quality lithium, silver, gold, nickel, copper and zinc prospects.

QMC’s current properties are in the Canadian province of Manitoba, one of Canada’s most productive, centrally located mining regions. These resources include the Irgon Lithium Mine project and two Volcanic Massive Sulphide (“VMS”) properties – the Rocky Lake and Rocky-Namew known collectively as the Namew Lake District Project – which contain base metal-rich mineral deposits. Excellent access and well-developed mining infrastructure to the company’s wholly-owned Irgon Lithium Mine Project offers significant value and ramps up the near-term production schedule, putting QMC in a position to take advantage of rising lithium prices.

The region’s historic resource estimate of lithium is well documented in a 1956 Assessment Report developed by a previous owner, Lithium Corporation of Canada Ltd. The project’s historical resource estimate of 1.2 million tons grading 1.51% lithium-oxide over a strike length of 365 meters and to a depth of 213 meters is being updated by QMC through a detailed channel sampling and subsequent drill program.

North Face Software Ltd. recently created an interactive 3-D model of the Irgon Dike utilizing all historical data derived from past drilling and underground work. The 3-D model clearly demonstrates that exploration and underground development has only taken place on the central portion of the dike, leaving significant potential to quickly increase tonnage.

The company’s latest assay results, obtained from 144 channel samples at QMC’s Irgon Lithium Mine Project, provided encouraging and positive results that compare favorably with the historic assays. QMC has received a drill permit from the Sustainable Development Office of the Manitoba government and is in the process of requesting and assessing bids from drilling contractors. The company plans to begin a 2,000-meter drill program to confirm the historic lithium oxide assay results documented in the historic 1953-54 drill program.

QMC’s experienced leadership team includes specialists in mineral exploration, geology, engineering, new business development, marketing and investor relations. The company’s team of qualified advisors includes consultant Bruce E. Goad, P.Geo., who has 40 years of experience in mineral exploration in Canada, Argentina, Asia and Africa. As a Qualified Person, Goad has worked on numerous deposit styles including rare element pegmatites, porphyry, banded iron formation (BIF) gold deposits, skarn, greisens,  and VMS. He has a wide and varied skill set which includes precious, base, industrial and rare metal projects with a sharp focus on gold exploration. Goad is the author of several scholarly publications on pegmatite granites of the southeastern Manitoba region.

The market for lithium has surged over the past three years with prices per metric ton tripling. The world’s rising demand for portable power can easily been seen in the electric vehicle and mobile device industries – both of which use lithium-based, renewable batteries as a power resource. QMC’s high potential prospects and experienced management team, both in geology and corporate finance, put QMC and its shareholders in an excellent position to take advantage of the lithium, precious and base metals markets.

QMC Quantum Minerals Corp. (QMCQF), closed the day's trading session at $0.23648, off by 1.47%, on 33,521 volume with 19 trades. The average volume for the last 3 months is 109,507 and the stock's 52-week low/high is $0.168/$1.46.

Recent News

chart

GreenBox POS, LLC (GRBX)

The QualityStocks Daily Newsletter would like to spotlight GreenBox POS, LLC (GRBX).

Leather wallets are fast becoming passé as cashless payments proliferate. Increasingly, smartphone users are finding electronic payment technology in their wallets. Digital developments have ushered in the era of the e-wallet, payment technology like that from GreenBox POS, LLC (OTC: GRBX), which makes paying electronically a whole lot easier.

GreenBox POS, LLC (GRBX) is a hardware and software technology company that builds customized payment solutions in different industries. The company is headquartered in San Diego, California, with offices in Seattle, Wash.; Las Vegas, Nevada; and Vancouver, British Columbia, Canada. GreenBox, which has been awarded five provisional patents for its blockchain-based technology, delivers a fully integrated, intuitive, easy-to-use, point of sale (POS) system for a variety of businesses across a multitude of different market sectors.

GreenBox develops all software in-house and with international subsidiaries, which allows the company to provide individualized electronics modifications in partnership with different vendors. Custom POS machines are available as an upgrade from existing solutions currently in use. First-time merchants can also take advantage of custom-built kiosk machines powered by blockchain technology, complete with e-wallet integration downloadable via Android or iOS apps, or via installed cash-loading kiosks.

GreenBox develops POS (point of sale) software and hardware solutions; DEL (delivery app, APIs to POS and PAY); PAY (payment app, providing financial APIs to all other components); and KIOSK (deposit, cash and E-wallet management). The following flagship products, services and custom hardware are currently available:

  • QuickCard – the QuickCard kiosk handles all cash issues, both for cashless operations and for legacy cash; performs direct and immediate deposits from cash to blockchain and confirms bank account availability within minutes. Accepts cash, debit/credit cards, or ACH directly to most banks while settling funds instantly. All records are stored securely on blockchain. No faster deposit solution is available in the regular and non-traditional banking systems (unless depositing cash directly into a cash machine connected to a bank branch).
  • POS Solutions – GreenBox software, developed in-house and with international subsidiaries, features operational compliance, financial audit prep, expense tracking, tax payments, register-specific features, and data fidelity controls (backup/restore, cloud security, privacy, etc.). GreenBox POS software is fully integrated with Del and Pay Systems and features front register mode and back-end admin mode, in addition to in-admin mode to manage employees, vendors, expenses, taxes and compliance. All records are stored on blockchain with data reliably secured and protected.
  • LOOPZ – This delivery software solution offers service dispatcher back-end technology with manual and automatic modes. The software is uniquely designed to be effectively utilized for mobile delivery service operations with full autonomous dispatch capabilities. LOOPZ provides the following features: two mobile apps (driver and consumer) running on Android and IOS; direct reporting to point of sale inventory and use of pay for instant settlements; separate escrow setup for tips and merchant sale; all data and information is securely hosted on a blockchain platform.

The management team at GreenBox includes CEO Fredi Nisan, who comes from the POS and merchant services business sector. He recently completed a successful exit in the POS and ERP business, which he founded and managed through the exit. Joining Nisan is Ben Errez, executive vice president, who comes from the investment, consulting and big software and hardware industries. His previous executive roles include positions at Microsoft (including engineering management of Microsoft Office for complex scripts); IBM (with which he had an exit); and Intel. Errez has also consulted the world’s biggest private economy, World Trade Center, on payment systems, security, reliability and privacy of software and hardware development.

GreenBox POS, LLC (GRBX), closed the day's trading session at $0.435, off by 2.25%, on 6,242 volume with 8 trades. The average volume for the last 3 months is 33,635 and the stock's 52-week low/high is $0.017/$1.95.

Recent News

chart

Sugarmade, Inc. (SGMD)

The QualityStocks Daily Newsletter would like to spotlight Sugarmade, Inc. (SGMD).

CannabisNewsWire ("CNW"), a multifaceted financial news and publishing company, today announces the publication of an editorial featuring Sugarmade, Inc. (OTCQB: SGMD), a client of CNW investing in products and brands with disruptive potential. To view the full publication, titled “Bumper Hemp Crops Promise Profit for Farmers and Cannabis Companies,” visit: http://cnw.fm/K4ZfN.

Sugarmade, Inc. (SGMD) one of the largest publicly traded hydroponics supply companies moving into the industrial hemp space, is a product and brand marketing company investing in products and brands with disruptive potential. Sugarmade’s brands include: ZenHydro.com; CarryOutSupplies.com; and BudLife. Headquartered in Monrovia, California, a city within Los Angeles county, Sugarmade has various business operations in diverse marketplaces including packaging and paper goods for various industries, agricultural supplies.

Sugarmade has expanded into the European hydroponics supply market with a growing base of orders taken through Amazon UK. Over the past few financial quarters, Sugarmade has seen revenue growth patterns expand geographically. As recently as mid-2017, the majority of hydroponic-related revenue growth was seen from California and other West Coast marketplaces, however growth is becoming more geographically dispersed among U.S. states where legalization has eased restriction. This movement into the United Kingdom further expands the base of geographic growth areas for Sugarmade.

Sugarmade recently launched a new corporate initiative in the booming industrial hemp and CBD, committing up to $1 million in capital over the next 12 months to invest in Hempistry, Inc., a privately held Nevada corporation. Hempistry has begun planting an ultra-high cannabidiol (CBD) industrial hemp strain on a land option it holds on 23,000 acres of prime Kentucky farmland. The strain of industrial hemp being grown by Hempistry is ultra-rich in CBD but contains less than 0.3 percent of THC, the psychoactive ingredient found in cannabis. The U.S. hemp industry is expected to produce well over $1 billion in revenues in 2018, with a compound annual growth rate of 14 percent through 2022, according to the Hemp Business Journal.

Demand for industrial hemp and products derived from hemp is soaring, with no let-up in sight, which the company sees as a “tremendous opportunity to become a supplier to this fast-growing sector,” said Chairman and CEO Jimmy Chan, who is also an advisor and minority shareholder of Hempistry.

Sugarmade’s investment into the market for high-CBD hemp is expected to be highly accretive for common shareholders in two ways. First, Sugarmade’s investment will be in the form of common shares in Hempistry allowing Sugarmade common shareholders to possibly benefit from any future initial public offering of Hempistry. Second, Sugarmade is expected to sign a supply agreement with Hempistry for cultivation supplies, which would be additive to corporate revenues.

Sugarmade has also completed a master market agreement with industry leader BizRight Hydroponics, Inc., a leading marketer and manufacturer of cannabis and hydroponic growth supplies, which offers a range of hydroponics-related products including: HPS grow lights, electronic ballasts, HPS bulbs, nutrient mixes, environmental control products, pH measurement and calibration solutions and storage products. BizRight operates the ZenHydro.com website and other e-commerce properties and sells various products to distributors and retailers. BizRight is expected to produce in excess of $30 million in revenues during 2017, with substantial growth expected for 2018.

Sugarmade division CarryOutSupplies.com, the leader in paper and plastic take-out supplies, serves nationwide customers by offering a wide array of high quality products that are cost-efficient, custom-made and delivered on time. This business unit currently serves 2,000 quick service restaurants, garnering from 30-40 percent of the market share. Sugarmade plans to expand operations via the addition of market share and the introduction of new product offerings.

Management

CEO Jimmy Chan is an experienced business executive instrumental in growing multiple business operations with a strong expertise in international trade and banking, and international manufacturing and importation. He is also the founder of CarryOutSupplies.com, a company that revolutionized the custom-printed paper supplies subsector of the quick service restaurant industry, which merged with Sugarmade in 2014.

Arman Tabatabaei serves as operations consultant, providing high-level, day-to-day strategic guidance and tactical operational supervision for all aspects of the corporation’s business. He is an expert at data collection and analysis relative to resource management, risk forecasting and profit and loss management.

Sugarmade specializes in growing and acquiring innovative brands to maximize value for company employees, shareholders and other stakeholders. Sugarmade believes its future is very bright as the company expands operations within the cultivation sector and rapidly increases its revenue base.

Sugarmade, Inc. (SGMD), closed the day's trading session at $0.1168, off by 9.46%, on 1,429,576 volume with 263 trades. The average volume for the last 3 months is 2,508,395 and the stock's 52-week low/high is $0.045/$0.43.

Recent News

chart

Youngevity International, Inc. (NASDAQ: YGYI)

The QualityStocks Daily Newsletter would like to spotlight Youngevity International, Inc. (YGYI).

Youngevity International, Inc. (NASDAQ: YGYI) is a leading omni-direct lifestyle company offering a hybrid of the direct selling business model that includes e-commerce and the power of social selling. Among the Top 100 Global Direct Selling Companies, Youngevity offers products from the six top selling retail categories: health/nutrition, home/family, food/beverage (including coffee), spa/beauty, apparel/jewelry, and a range of innovative services. Created through the 2011 merger of Youngevity Essential Life Sciences with Javalution® Coffee Company, today’s Youngevity International Inc. is a virtual worldwide Main Street of products and services under one corporate entity that supports a healthy and empowered lifestyle.

Youngevity International is dedicated to improving lifestyles through the universal desires of vibrant health and flourishing economics. Catering to health-conscious consumers, Youngevity believes that combining the best of the direct selling industry with the fundamentals and capabilities of a traditional business model will maximize shareholder value. The company’s Nutritional, Lifestyle and Telecommunications products and services are distributed through a global network of Preferred Customers and Distributors.

Youngevity’s wholly owned CLR Roasters LLC business line offers quality branded and private label coffee to retail stores, office coffee services, hospitality, food services, distributors, convenience, petrol stores and vending businesses. Today, CLR Roasters is the largest coffee provider for cruise lines in North America and the second largest roaster in the state of Florida. Producing a consistent premium product with superior taste, CLR Roasters has earned numerous certifications that demonstrate the company’s commitment to the craft of providing the highest quality coffee products using the best practice standards available.

Youngevity, operating in the direct-selling channel, is rapidly expanding its product and distributor base through acquisitions and mergers under an innovative concept called “the Network Cloud” that provides other direct selling companies with a home base. The company’s YoungevityGO2 mobile distributor app, a new technology-driven web platform supporting expansion of global e-commerce and social selling platforms, is available on Google Play and the App Store. In addition to the Network Cloud concept, Youngevity International owns CLR Coffee Roasters which operates a traditional coffee roasting business offering a JavaFit® gourmet product line that vertically integrates with Youngevity and its growing network of direct marketers.

Youngevity International offers more than 1,000 high quality, technologically advanced products under the following categories:

  • Health and Nutrition
  • Home and Family
  • Food and Beverage
  • Spa and Beauty
  • Fashion
  • Essential Oils
  • Photo and scrapbooking
  • Services for Home and Business

Youngevity International Inc. has compiled a best-in-class management team with a strong track record of success in private and public companies. Steve Wallach, CEO, has nearly two decades of sales and network marketing experience and has successfully guided Youngevity International Inc. to become an international, publicly-traded direct marketing company positioned for worldwide growth. Dave Briskie, president and CFO, has shepherded the company’s development into a fully vertical coffee roasting and distribution company that owns the direct marketing brand JavaFit® and the retail brand, Café La Rica.

Youngevity has also attracted a stunning group of Brand Evangelists who endorse its products. Among these are actress, author and well-known health and wellness activist Marilu Henner; former NBA basket player, Mike “Stinger” Glenn; former NFL wide receiver Drew Pearson; “Greatest Natural Bodybuilder in the World” Gene Nelson; and WNBA champion, Olympic gold medalist Delisha Jones.

Youngevity International, Inc. (NASDAQ: YGYI), closed the day's trading session at $8.84, up 8.20%, on 492,871 volume with 2,273 trades. The average volume for the last 3 months is 495,807 and the stock's 52-week low/high is $3.1674/$16.25.

Recent News

chart

Green Hygienics Holdings Inc. (GRYN)

The QualityStocks Daily Newsletter would like to spotlight Green Hygienics Holdings Inc. (GRYN).

Green Hygienics Holdings Inc. (GRYN) is a full-scope, premium cannabis cultivation company targeting the high-end medical and adult-use recreational market. With more than 25 years of experience in agricultural science and innovation, Green Hygienics is establishing itself as a leader in the advancement of science-driven cannabis cultivation systems. The company will grow by generating revenues from the sales of premium grade cannabis products, developing and licensing valuable IP, making strategic acquisitions, and creating trusted global consumer brands.

The company has integrated and is developing its own IP assets related to proprietary systems and apparatus, software, algorithms and custom-engineered hardware. This provides ultimate efficiencies in a commercially controlled cultivation environment. Utilizing the advantages of hybrid-aeroponics, Green Hygienics creates a sterile growing environment that produces consistent, high-quality product while maintaining the lowest possible carbon footprint. The company utilizes state-of-the-art, quality-controlled commercial cultivation methodology to assure production of pharmaceutical-grade cannabis at much higher yields and greatly reduced costs.

Hybrid-aeroponics produces quality cannabis faster than traditional methods since it doesn’t require natural sunlight or soil and can be operational and produce plants anywhere. Plants grown under aeroponic conditions receive water and nutrients directly to their roots via a fine mist in a controlled environment, dramatically reducing spoilage while keeping the product organic and the environment pest-free. The plants are given the exact amount of nutrients and moisture precisely when needed. Green Hygienics maintains ultimate control over every aspect of this cultivation process, which allows the company to operate with conservation of natural resources in mind. The technology that uses 90-95 percent less water and does not require the use of pesticides or fungicides.

Additionally, the company’s state-of-the-art engineered, controlled environments include electrical, mechanical and HVAC designs that meet mandatory fire and energy codes while improving energy efficiency significantly.

Through these practices, Green Hygienics is establishing itself as a leader in the advancement of science-driven cannabis cultivation systems. The company continues to develop and incubate software as well as engineer hardware to provide additional control over the commercial cultivation method. The company’s science-based approach reveals any growth anomalies before the human eye can see them. This makes it possible to monitor all facets of production, identify cultivation problems based upon scientific data, and implement immediate corrective action, if needed.

The future of commercial cannabis cultivation hinges on using science to control the growing environment in order to remain competitive and deliver a premium grade of product on a consistent basis. The company holds a competitive advantage through its ability to produce premium cannabis products at a significantly lower cost per gram than direct competitors and others in the cannabis industry.

Innovations within the sector that create efficiencies and successful brands will become highly valued. Green Hygienics and its forward-thinking management team are constantly studying the market dynamics of the cannabis industry in North America and abroad while actively pursuing possible expansion opportunities. The company is headquartered in Las Vegas, Nevada and establishing operations in San Diego, California, targeting the $5 billion California cannabis market.

Green Hygienics Holdings Inc. (GRYN), closed the day's trading session at $0.4937, up 9.71%, on 1,089 volume with 5 trades. The average volume for the last 3 months is 60,500 and the stock's 52-week low/high is $0.0099/$0.508.

Recent News

chart

American Premium Water Corp. (HIPH)

The QualityStocks Daily Newsletter would like to spotlight American Premium Water Corp. (HIPH).

American Premium Water Corp. (HIPH), headquartered in Playa Vista, California, is a diversified holding company, manufacturer, distributor and marketer of branded consumer products. HIPH, the acronym for “Hi-Power of Hydro,” maintains a portfolio of subsidiaries catering to the health-conscious consumer and luxury fashion brand connoisseur. The company’s two main pillars focus on the development of health and beauty biotech, dedicated to unlocking the power of hydrogen and nanotechnologies. Paired with cannabidiol or “CBD” in a unique beverage, the technology is proving to be a significant health and wellness option for astute consumers.

Among the company’s holdings are:

  • LALPINA Hydro beverages mix hydrogen with nanotechnology into consumer beverages that combine the best of health, nutrition and fitness to deliver short and long-term therapeutic health benefits. LALPINA Hydro utilizes atomic molecular hydrogen, or diatomic hydrogen, which converts antioxidants in the body to H2O to further enhance hydration, which helps increase endurance, reduce lactic acid and melt away fatigue. Over 500 peer-reviewed articles demonstrate hydrogen to have therapeutic potential in essentially every organ of the human body and in 150 different human disease models.
  • LALPINA Hydro CBD is a technically superior CBD-infused beverage. Using hydro and nanotechnology, LALPINA Hydro CBD encapsulates water molecules with cannabidiol molecules, making them infinitely more bioavailable and accelerating delivery to the body’s cells and tissues. Each bottle of LALPINA Hydro CBD contains 3 million nanograms of CBD free from the psychoactive compound THC (tetrahydrocannabinol). HIPH is the first to introduce a hydro-nano CBD-infused beverage on the market, which is a more effective delivery mechanism for administering CBD into the blood stream than traditional beverages or oils, with up to a 90 percent higher absorption rates.

The company recently signed a distribution agreement for its subsidiary, LALPINA Hydro CBD, to sell its beverages to two SinglePoint, Inc. (OTCQB: SING) e-commerce channels: SingleSeed.com and DIGSHydro.com. SING is a technology and investment company with a portfolio that includes mobile payments, blockchain solutions and ancillary cannabis services. HIPH will drop ship its product to the customers.

HIPH CEO Ryan Fishoff said the e-commerce arrangements “could bring in excess of a million of revenue over the life of the agreement.” The agreement serves as a pillar of the company’s e-commerce distribution strategy, driving awareness and impressions for the LALPINA brand.

In addition, HIPH seeks to market emerging fashion brands and leverage its relationship with classic retail partners while incorporating disruptive blockchain technologies to expand its retail footprint with the following:

  • Gents, a producer of luxury hats and other fine accessories and apparel, was acquired in September 2017. Gents is distributed across many luxury retail outlets including Saks Fifth Avenue, Bloomingdales, Nordstrom, and other high-end channels. The company added the Worthy streetwear brand to its portfolio in June 2018.
  • HIPH also acquired the license to operate the FashionCoinX exchange, a blockchain exchange focused on creating utility tokens for the fashion industry, and created THRD Coin, a multi-branded utility rewards token that is also the first token to be traded on the exchange. The company is leveraging its retail footprint and expertise in the fashion and apparel space with the burgeoning blockchain sector.

American Premium Water Corp. (HIPH), closed the day's trading session at $0.0588, up 1.55%, on 13,279,252 volume with 542 trades. The average volume for the last 3 months is 17,419,814 and the stock's 52-week low/high is $0.0035/$0.1319.

Recent News

chart

Golden Developing Solutions, Inc. (DVLP)

The QualityStocks Daily Newsletter would like to spotlight Golden Developing Solutions, Inc. (DVLP).

Golden Developing Solutions, Inc. (DVLP), an emerging leader in ancillary software and the cannabidiol (CBD) products marketplace, provides business services and/or products supporting the cannabis industry including an online retail business for CBD, hemp oil and health/wellness related products.

Global acceptance of cannabis and related CBD products continues to increase as North America advances toward favorable legislation. Canada legalized recreational cannabis in October 2018, and the United States has 30 states and the District of Columbia allowing either recreational or medical cannabis, or both. Voters in four additional U.S. states will consider marijuana initiatives on the November 2018 ballot. The global legal cannabis market is projected to reach USD$146 billion by the end of 2025, with a greater acceptance of medical cannabis products as a driving factor, according to Grand View Research.

DVLP is taking advantage of consumer demand for CBD products through its wholly owned Pura Vida Vitamins, LLC subsidiary, which recently launched a direct-to-consumer website (www.PuraVidaVitamins.com) and commenced sales of Pura Vida branded products. Pura Vida merchandise includes hemp and CBD-related products and other products focusing on health and lifestyle which are available through established wholesale and distribution channels. In addition, a line of CBD pet supplements and other products are in development.

DVLP recently acquired “Where’s Weed” (Layer Six Media LLC DBA “Where’s Weed”) and its primary asset, WheresWeed.com. Where’s Weed is an American cannabis technology company known for connecting medical and recreational cannabis users with trusted local marijuana businesses in their communities. As a rapidly growing community-based online resource for cannabis consumers with a host of user-friendly services, Where’s Weed offers a sophisticated mobile app with strong traction and powerful growth potential as the North American legal cannabis market continues to expand exponentially.

WheresWeed.com has a large and expanding reach with nearly 3 million pageviews per month. In addition, the WheresWeed mobile app, available in both iOS and Android, has been downloaded over 80,000 times, proving to be complementary to DVLP’s objective to capitalize on the massive growth curve in the marijuana space.

“The huge flood of new growers and producers is likely to create oversupply in the near term, narrowing margins for major producers,” says DVLP CEO Stavros Triant. “However, this should actually increase the net number of new consumers in the marketplace, further reinforcing the enormous growth potential for hub service providers in the space that are situated on high-traffic internet real estate, which is exactly how we view the Where’s Weed property.”

The company’s move into the lucrative C-store snack market was solidified with a material purchase order for CBD oils from a major distributor specializing in the snack foods and accessories to the convenience store and gas station market. The order represents significant progress as DVLP gears up its ready-made snack distribution strategy for its CBD products.

“We are extremely excited about the launch of our CBD product line with this distributor,” Triant states. “The C-Store strategy dovetails perfectly with our direct marketing strategy through our primary online retail channel, and we have indications from the distributor that, if this initial test order goes well, successive Purchase Orders could be significant and underpin strong sales growth in Q1 2019.”

Golden Developing Solutions, Inc. (DVLP), closed the day's trading session at $0.0237, up 0.85%, on 181,564 volume with 11 trades. The average volume for the last 3 months is 735,234 and the stock's 52-week low/high is $0.0125/$0.14.

Recent News

chart

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits

QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

ActionStockPicksAgressive StocksBetting On Wall StreetCannabisNewsWireGot Stocks?Got Stock Tips?Green Car StocksGreen Energy StocksGreen On The StreetHomeRunStocksMissionIRMissionIR MediaMissionPRMissionSMRNetworkNewsWireQualityStocks MediaQStocksQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsStock BeatsStocks To Buy NowTerrificStocksTiny GemsTip.usTouchdownStocksDaily ToutTraderPower

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.